Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
  1. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 1,064 shares at $48.22 ($51,309)
  2. 4 Open-market sale PRESIDENT AND COO sold 3,177 shares at $47.92 ($152,256)
  3. 4 Option exercise CHIEF FINANCIAL OFFICER acquired 2,667 shares (option exercise)
  4. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 902 shares at $47.92 ($43,228)
  5. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 6,837 shares at $47.92 ($327,658)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale CHIEF MEDICAL OFFICER sold 6,969 shares at $45.86 ($319,598)
  12. 4 Open-market sale PRESIDENT AND COO sold 1,998 shares at $42.82 ($85,545)
  13. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,489 shares at $42.82 ($320,644)
  14. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 750 shares at $42.82 ($32,111)
  15. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 2,500 shares at $47.10 ($117,752)
  16. 4 Grant or award CHIEF MEDICAL OFFICER acquired 118 shares (grant or award)
  17. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 475 shares (grant or award)
  18. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 65 shares (grant or award)
  19. 4 Gift Director gave 102,788 shares (gift)
  20. 4 Open-market buy Director bought 115 shares at $37.40 ($4,301)

Page 6 of 18 · 356 filings